Breast Cancer: How Much Progress Have We Made?
After thirty years of Breast Cancer Awareness Month, actual progress against the disease has not met expectations, with over 40,000 deaths from the disease annually in the United States.
Exploring progress in cancer research from the patient perspective
After thirty years of Breast Cancer Awareness Month, actual progress against the disease has not met expectations, with over 40,000 deaths from the disease annually in the United States.
Learning to recognize the signs and symptoms of gynecologic cancers is an essential part of “awareness” during Gynecologic Cancer Awareness Month, as is advocating for appropriate levels of research funding.
Ken Burns’ cancer film is a compelling story of the progress that’s been made against cancer over the last several decades, but it also makes clear the need for continuing investment in research to build on that progress.
Taking a look back at major stories about developments in cancer research in 2014.
Focus on the treatment needs of patients with metastatic breast cancer is a critical research priority.
Breast cancer screening has become widespread, but misperceptions about the disease are also common. True awareness, the kind that will lead to action to save lives, needs to start with facts like these.
Today, just like twenty years ago, we continue to hear about promising new research but we still know little about the causes of breast cancer, and mortality from the disease remains high.
A new set of findings from The Cancer Genome Atlas project looks at cancer genome sequencing in a different way–comparing mutations across types of cancer.
While mammography screening has increased as a result of “awareness” campaigns, we are far from being able to declare success in the fight against breast cancer.
In the last twenty years, there have been some advances in breast cancer treatment and many more women are screened each year, but these advances have not brought about transformational change in the way breast cancer is treated or in mortality from the disease.